应用场景:针对化学分析用途,(113558-89-7 1L1K8X5DF9 E 4031 Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)- E-4031 2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfo
理化性质 Physical & Chemical Properties
中文名称
分子式
C21H27N3O3S
分子量
401.52 g/mol
外观形态
淡黄色至黄色结晶性粉末。(含硫化合物特征性气味)
纯度
97%+
储存条件
阴凉处(≤25°C)保存,避光,密封防潮
溶解性参考
可溶于DMSO、DMF、甲醇
稳定性
空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型
药物标准品
子类
原料药标准品
不饱和度(DBE)
10.0
UV特征
有紫外吸收
结构特征
含芳环
CAS登记年份(估)
1989年
含氮原子数
3
含硫原子数
1
相关专利 Related Patents
Schröder R, Rossi M, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3908810 A1, 2024-12-17.
O'Brien P Q, Park J H, Johnson M A. "Method for the Synthesis of 113558-89-7
1L1K8X5DF9
E 4031
Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)-
E-4031
2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine
N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide
UNII-1L1K8X5DF9" [P]. US Patent, US 9342272 B2, 2023-04-20.
Hughes D C, Patel M V, Kumar R. "A Process for Preparing High-Purity 113558-89-7
1L1K8X5DF9
E 4031
Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)-
E-4031
2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine
N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide
UNII-1L1K8X5DF9" [P]. US Patent, US 10889157 B2, 2022-10-13.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2013, 2343, 5803-5816.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 233, (9), 7877-7900.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 113558-89-7
1L1K8X5DF9
E 4031
Methanesulfonamide, N-(4-((1-(2-(6-methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)-
E-4031
2-Methyl-6-(2-(4-(4-methylsulfonylamino)benzoylpiperidin-1-yl)ethyl)pyridine
N-(4-((1-(2-(6-Methyl-2-pyridinyl)ethyl)-4-piperidinyl)carbonyl)phenyl)methanesulfonamide
UNII-1L1K8X5DF9 Using HRMS and NMR". Molecules, 2015, 746, (4), 9106-9128.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2015, 828, 1771-1789.